# www.nature.com/scientificreports/

|ID|Description|
|---|---|
|hsa04940|Type I diabetes mellitus|
|hsa05332|Graft-versus-host disease|
|hsa05140|Leishmaniasis|
|hsa04612|Antigen processing and presentation|
|hsa00830|Retinol metabolism|
|hsa05030|Cocaine addiction|
|hsa00982|Drug metabolism—cytochrome P450|

# Continued

|Enrichment Score|pvalue|qvalue|Core_enrichment|
|---|---|---|---|
|0.725|&lt; 0.001|&lt; 0.001|HLA-DRB4/HLA-DMB/HLA-DMA/HLA-DPB1/HLA-DRA/HLA-DOB/GZMB/HLA-DQB1/HLA-DRB1/HLA-DPA1/HLA-DQA1/PRF1/FAS/HLA-F/CD86/CD28/HLA-B/HLA-DOA/HLA-C/HLA-E|
|0.713|&lt; 0.001|&lt; 0.001|HLA-DRB4/HLA-DMB/HLA-DMA/HLA-DPB1/HLA-DRA/HLA-DOB/GZMB/HLA-DQB1/HLA-DRB1/HLA-DPA1/HLA-DQA1/PRF1/FAS/HLA-F/CD86/CD28/HLA-B/HLA-DOA/HLA-C/HLA-E/KLRC1/FASLG/HLA-G|
|0.684|&lt; 0.001|&lt; 0.001|NCF1/HLA-DRB4/FCGR1A/HLA-DMB/HLA-DMA/ITGB2/STAT1/CYBB/HLA-DPB1/HLA-DRA/HLA-DOB/PRKCB/HLA-DQB1/PTPN6/HLA-DRB1/HLA-DPA1/HLA-DQA1/ITGAM/FCGR3A/FCGR2A/CYBA/MARCKSL1/FCGR2C/NCF4/NCF2/FCGR3B/MAPK13/ITGA4/JAK2|
|0.679|&lt; 0.001|&lt; 0.001|HLA-DRB4/HLA-DMB/HLA-DMA/HLA-DPB1/HLA-DRA/HLA-DOB/RFX5/TAP1/HLA-DQB1/TAPBP/CD8A/CD74/HLA-DRB1/HLA-DPA1/HLA-DQA1/IFI30/CTSS/CD4/HLA-F/CIITA/CTSB/PSME1/CALR/HLA-B/HLA-DOA/HLA-C/HLA-E/KLRC1/LGMN/CD8B/HLA-G|
|− 0.525|0.008|0.024|RDH16/RETSAT/CYP1A2/CYP3A4/ALDH1A2/CYP2B6/ALDH1A1/CYP2W1/ALDH1A3/DHRS3/ADH5/AOX1/CYP26B1/ADH1C/ADH1B|
|− 0.529|0.007|0.023|CREB5/ATF4/SLC6A3/JUN/MAOA/FOSB|
|− 0.535|0.004|0.016|GSTM5/CYP2B6/GSTM3/GSTT2/GSTA4/GSTM1/GSTM2/ADH5/HPGDS/AOX1/ADH1C/FMO2/MAOA/ADH1B|

Scientific Reports | (2023) 13:9754 | https://doi.org/10.1038/s41598-023-36833-7 | Vol.:(0123456789)